192 related articles for article (PubMed ID: 32118627)
1. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
Liu Y; Jelloul F; Zhang Y; Bhavsar T; Ho C; Rao M; Lewis NE; Cimera R; Baik J; Sigler A; Sen F; Yabe M; Roshal M; Landgren O; Dogan A; Xiao W
Am J Surg Pathol; 2020 Jun; 44(6):838-848. PubMed ID: 32118627
[TBL] [Abstract][Full Text] [Related]
2. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
5. Plasmablastic transformation of multiple myeloma.
Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
[TBL] [Abstract][Full Text] [Related]
8. [Unusual presentation of plasma cell myeloma].
Bürgesser MV; Basquiera AL; Diller A
Medicina (B Aires); 2012; 72(3):251-4. PubMed ID: 22763165
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M
J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408
[TBL] [Abstract][Full Text] [Related]
10. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
Sher T; Miller KC; Lee K; Chanan-Khan A
Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386
[TBL] [Abstract][Full Text] [Related]
11. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of plasma cell morphology in multiple myeloma.
Carter A; Hocherman I; Linn S; Cohen Y; Tatarsky I
Cancer; 1987 Sep; 60(5):1060-5. PubMed ID: 3607725
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Involvement in Plasma Cell Myeloma.
Panse G; Subtil A; McNiff JM; Glusac EJ; Ko CJ; Galan A; Myung P; Xu ML
Am J Clin Pathol; 2021 Jan; 155(1):106-116. PubMed ID: 32885235
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
Eladl E; Chang H
Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
[No Abstract] [Full Text] [Related]
15. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
16. Genetic Abnormalities in Extramedullary Multiple Myeloma.
McAvera R; Quinn J; Murphy P; Glavey S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511018
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of plasma cell morphology in multiple myeloma.
Paule B; Quillard J; Bisson M; Kahn MF; Massias P
Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma: significance of plasmablastic subtype in morphological classification.
Greipp PR; Raymond NM; Kyle RA; O'Fallon WM
Blood; 1985 Feb; 65(2):305-10. PubMed ID: 3967084
[TBL] [Abstract][Full Text] [Related]
19. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
[TBL] [Abstract][Full Text] [Related]
20. Incidental diagnosis of a rare pancreatic plasmacytoma with plasmablastic features.
Iqbal S; Agrawal S; Desai K; Paravathaneni M; Thirumaran R
Proc (Bayl Univ Med Cent); 2023; 36(1):85-86. PubMed ID: 36578587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]